Zhong Yan, Armbrecht Harvey J, Christakos Sylvia
Department of Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, New Jersey 07103, USA.
J Biol Chem. 2009 Apr 24;284(17):11059-69. doi: 10.1074/jbc.M806561200. Epub 2009 Mar 4.
Although parathyroid hormone (PTH) induces 25-hydroxyvitamin D(3) (25(OH)D(3)) 1alpha-hydroxylase (1alpha(OH)ase) under hypocalcemic conditions, previous studies showed that calcitonin, not PTH, has an important role in the maintenance of serum 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) under normocalcemic conditions. In this study we report that 1alpha(OH)ase transcription is strongly induced by calcitonin in kidney cells and indicate mechanisms that underlie this regulation. The transcription factor C/EBPbeta is up-regulated by calcitonin in kidney cells and results in a significant enhancement of calcitonin induction of 1alpha(OH)ase transcription and protein expression. Mutation constructs of the 1alpha(OH)ase promoter demonstrate the importance of the C/EBPbeta binding site at -79/-73 for activation of the 1alpha(OH)ase promoter by calcitonin. The SWI/SNF chromatin remodeling complex was found to cooperate with calcitonin in the regulation of 1alpha(OH)ase. Chromatin immunoprecipitation analysis showed that calcitonin recruits C/EBPbeta to the 1alpha(OH)ase promoter, and Re-chromatin immunoprecipitation analysis (sequential chromatin immunoprecipitations using different antibodies) showed that C/EBPbeta and BRG1, an ATPase that is a component of the SWI/SNF complex, bind simultaneously to the 1alpha(OH)ase promoter. These findings are the first to address the dynamics between calcitonin, C/EBPbeta, and SWI/SNF in the regulation of 1alpha(OH)ase and provide a mechanism, for the first time, for calcitonin induction of 1alpha(OH)ase. Because plasma calcitonin as well as 1,25(OH)(2)D(3) have been reported to be increased during pregnancy and lactation and in early development, these findings suggest a mechanism that may account, at least in part, for the increase in plasma 1,25(OH)(2)D(3) during these times of increased calcium requirement.
尽管甲状旁腺激素(PTH)在低钙血症条件下可诱导25-羟基维生素D3(25(OH)D3)1α-羟化酶(1α(OH)ase),但先前的研究表明,在正常血钙条件下,降钙素而非PTH在维持血清1,25-二羟基维生素D3(1,25(OH)2D3)水平方面起重要作用。在本研究中,我们报告降钙素可在肾细胞中强烈诱导1α(OH)ase转录,并指出了这种调节作用的潜在机制。转录因子C/EBPβ在肾细胞中被降钙素上调,导致降钙素对1α(OH)ase转录和蛋白表达的诱导作用显著增强。1α(OH)ase启动子的突变构建体证明了位于-79/-73处的C/EBPβ结合位点对于降钙素激活1α(OH)ase启动子的重要性。发现SWI/SNF染色质重塑复合物在1α(OH)ase的调节中与降钙素协同作用。染色质免疫沉淀分析表明,降钙素将C/EBPβ募集至1α(OH)ase启动子,再染色质免疫沉淀分析(使用不同抗体进行连续染色质免疫沉淀)表明,C/EBPβ和BRG1(一种作为SWI/SNF复合物组分的ATP酶)同时结合至1α(OH)ase启动子。这些发现首次揭示了降钙素、C/EBPβ和SWI/SNF在1α(OH)ase调节中的动态关系,并首次为降钙素诱导1α(OH)ase提供了一种机制。由于据报道孕期、哺乳期及早期发育期间血浆降钙素以及1,25(OH)2D3均会升高,这些发现提示了一种机制,该机制可能至少部分解释了在这些钙需求增加时期血浆1,25(OH)2D3升高的原因。